Trp53
M. musculus
transformation related protein 53
What the model saw
Gene: Trp53 Organism: Mus musculus Known functions: transformation related protein 53. cellular tumor antigen p53. ATP-dependent DNA/DNA annealing activity. DNA binding. DNA-binding transcription activator activity, RNA polymerase II-specific. DNA-binding transcription factor activity. DNA-binding transcription factor activity, RNA polymerase II-specific. DNA-binding transcription repressor activity, RNA polymerase II-specific. MDM2/MDM4 family protein binding. RNA polymerase II cis-regulatory region sequence-specific DNA binding. RNA polymerase II-specific DNA-binding transcription factor binding. TFIID-class transcription factor complex binding. chromatin binding. cis-regulatory region sequence-specific DNA binding. copper ion binding. core promoter sequence-specific DNA binding. disordered domain specific binding. enzyme binding. general transcription initiation factor binding. histone deacetylase binding. identical protein binding. mRNA 3'-UTR binding. molecular condensate scaffold activity. molecular function activator activity. p53 binding. promoter-specific chromatin binding. protease binding. protein binding. protein heterodimerization activity. protein phosphatase 2A binding. protein-folding chaperone binding. receptor tyrosine kinase binding. transcription cis-regulatory region binding. transcription coactivator binding. ubiquitin protein ligase binding.
View unredacted entry
transformation related protein 53. cellular tumor antigen p53. ATP-dependent DNA/DNA annealing activity. DNA binding. DNA-binding transcription activator activity, RNA polymerase II-specific. DNA-binding transcription factor activity. DNA-binding transcription factor activity, RNA polymerase II-specific. DNA-binding transcription repressor activity, RNA polymerase II-specific. MDM2/MDM4 family protein binding. RNA polymerase II cis-regulatory region sequence-specific DNA binding. RNA polymerase II-specific DNA-binding transcription factor binding. TFIID-class transcription factor complex binding. chromatin binding. cis-regulatory region sequence-specific DNA binding. copper ion binding. core promoter sequence-specific DNA binding. disordered domain specific binding. enzyme binding. general transcription initiation factor binding. histone deacetylase binding. identical protein binding. mRNA 3'-UTR binding. molecular condensate scaffold activity. molecular function activator activity. p53 binding. promoter-specific chromatin binding. protease binding. protein binding. protein heterodimerization activity. protein phosphatase 2A binding. protein-folding chaperone binding. receptor tyrosine kinase binding. transcription cis-regulatory region binding. transcription coactivator binding. ubiquitin protein ligase binding.
Solver output
Trp53 (p53) is a master transcription factor that, upon activation, drives transcriptional programs promoting cell cycle arrest, apoptosis, and cellular senescence. While p53 is essential for tumor suppression, its hyperactivation accelerates organismal aging by promoting irreversible senescence and stem cell exhaustion — a well-documented trade-off in mouse models where constitutively active p53 variants extend cancer resistance but shorten lifespan. p53 directly transactivates senescence effectors such as p21 (Cdkn1a) and components of the senescence-associated secretory phenotype (SASP), and its binding to MDM2/MDM4 family proteins regulates its own stability and activity. Gain-of-function or chronic p53 activity depletes stem cell pools and impairs tissue regeneration, hallmarks of accelerated aging. Thus, while basal p53 function is necessary, its net effect on longevity in mice is anti-longevity due to its dominant role in driving cellular senescence and stem cell exhaustion over the organism's lifespan.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted "anti_longevity" but the ground truth is "pro_longevity." The model's reasoning is partially valid in that p53 hyperactivation can accelerate aging, but it misapplies this to the gene's overall longevity influence. In mice, Trp53 is classified as pro_longevity because loss of p53 function leads to early cancer death and reduced lifespan, while normal p53 activity is essential for tumor suppression and longevity. The model correctly identifies the senescence/stem cell exhaustion trade-off but incorrectly concludes this makes p53 net anti-longevity. The GenAge classification reflects that p53 promotes longevity (primarily through tumor suppression), not that it shortens lifespan. The model's reasoning about constitutively active p53 variants is a nuanced point but doesn't apply to the wild-type gene's overall longevity influence. Confidence of 0.72 on a wrong answer is notable.
Raw API responses
solver
{
"reasoning": "Trp53 (p53) is a master transcription factor that, upon activation, drives transcriptional programs promoting cell cycle arrest, apoptosis, and cellular senescence. While p53 is essential for tumor suppression, its hyperactivation accelerates organismal aging by promoting irreversible senescence and stem cell exhaustion — a well-documented trade-off in mouse models where constitutively active p53 variants extend cancer resistance but shorten lifespan. p53 directly transactivates senescence effectors such as p21 (Cdkn1a) and components of the senescence-associated secretory phenotype (SASP), and its binding to MDM2/MDM4 family proteins regulates its own stability and activity. Gain-of-function or chronic p53 activity depletes stem cell pools and impairs tissue regeneration, hallmarks of accelerated aging. Thus, while basal p53 function is necessary, its net effect on longevity in mice is anti-longevity due to its dominant role in driving cellular senescence and stem cell exhaustion over the organism's lifespan.",
"confidence": 0.72,
"key_pathways": [
"p53-p21 senescence pathway",
"MDM2-p53 regulatory axis",
"p53-dependent apoptosis and stem cell exhaustion"
],
"mechanism_class": "cellular_senescence",
"longevity_influence": "anti_longevity"
}advisor
{
"notes": "The model predicted \"anti_longevity\" but the ground truth is \"pro_longevity.\" The model's reasoning is partially valid in that p53 hyperactivation can accelerate aging, but it misapplies this to the gene's overall longevity influence. In mice, Trp53 is classified as pro_longevity because loss of p53 function leads to early cancer death and reduced lifespan, while normal p53 activity is essential for tumor suppression and longevity. The model correctly identifies the senescence/stem cell exhaustion trade-off but incorrectly concludes this makes p53 net anti-longevity. The GenAge classification reflects that p53 promotes longevity (primarily through tumor suppression), not that it shortens lifespan. The model's reasoning about constitutively active p53 variants is a nuanced point but doesn't apply to the wild-type gene's overall longevity influence. Confidence of 0.72 on a wrong answer is notable.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 3,
"ground_truth_questionable": true
}